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Rab27A is required for actin-based melanosome
transport in mammalian skin melanocytes through
its interactionwithaspecificeffector, Slac2-a/melano-
philin. Mutations that disrupt the Rab27A/Slac2-a in-
teraction cause human Griscelli syndrome. The other
Rab27 isoform, Rab27B, also binds all of the known
effectors of Rab27A. In this study, we determined
the crystal structure of the constitutively active form
of Rab27B complexed with GTP and the effector do-
main of Slac2-a. The Rab27B/Slac2-a complex ex-
hibits several intermolecular hydrogen bonds that
were not observed in the previously reported
Rab3A/rabphilin complex. A Rab27A mutation that
disrupts one of the specific hydrogen bonds with
Slac2-a resulted in the dramatic reduction of Slac2-a
binding activity. Furthermore, we generated a Rab3A
mutant that acquires Slac2-a binding ability by trans-
planting four Rab27-specific residues into Rab3A.
These findings provide the structural basis for the
exclusive association of Slac2-a with the Rab27 sub-
family, whereas rabphilin binds several subfamilies,
including Rab3 and Rab27.
INTRODUCTION
The Rab family belongs to the monomeric Ras-like GTPase su-
perfamily, and it is considered to be essential for the control of
intracellular membrane trafficking in all eukaryotic cells (Zerial
and McBride, 2001; Pfeffer, 2005; Schwartz et al., 2007). Rab,
like other G proteins, functions as a molecular switch by cycling
between two nucleotide-bound states, a GDP-bound inactive
state and a GTP-bound active state. The GTP-bound active
form of Rab interacts with a specific effector molecule, and the
Rab/effector complex promotes membrane trafficking (Zerial
and McBride, 2001; Pfeffer, 2005; Schwartz et al., 2007). More
than 60 Rab isoforms have been reported in humans (Bock
et al., 2001; Pereira-Leal and Seabra, 2001), and they appear
to be present on distinct organelle membranes, where they reg-
ulate certain types (or distinct steps) of membrane trafficking. To
understand the specificity of Rab-mediated membrane traffick-1478 Structure 16, 1478–1490, October 8, 2008 ª2008 Elsevier Ltding, it is important to identify the Rab effector molecules, and
a number of putative effectors of Rab isoforms have been iden-
tified during the past decade (Grosshans et al., 2006). The struc-
tures of several Rab/effector complexes have been determined
(Ostermeier and Brunger, 1999; Zhu et al., 2004; Wu et al.,
2005; Eathiraj et al., 2005, 2006; Shiba et al., 2006; Jagoe
et al., 2006). These crystallographically analyzed Rab effectors
can bind several distinct Rab subfamilies—e.g., rabphilin binds
to Rab3, Rab8, and Rab27 (Kuroda et al., 2002; Fukuda et al.,
2004); rabaptin5 to Rab4 and Rab5 through distinct domains
(Vitale et al., 1998); RILP to Rab7 and Rab34 (Wang et al.,
2004); FIP2/3 to Rab11 and Rab25 (Hales et al., 2001); and rabe-
nosyn-5 to Rab4 and Rab14 through one domain, and to Rab5,
Rab22, and Rab24 through the other (Eathiraj et al., 2005). A
structural comparison of two distinct rabenosyn-5 effector
domains complexed with Rab4 or Rab22 revealed the highly se-
lective recognition of distinct Rab subfamilies through the inter-
action with the switch and interswitch regions. However, the
structural basis of the specificity between other Rab effectors
and their cognate Rab molecules remains elusive.
Rab27 is evolutionarily conserved from lower invertebrates to
mammals, and there are two Rab27 isoforms (Rab27A and
Rab27B) in human and mouse. Rab27A is a key player in regu-
lated secretion by various secretory cells, as well as in melano-
some transport in skin melanocytes, through interactions with
cell-type-specific effector molecules (Hammer and Wu, 2002;
Fukuda, 2005). Rab27A is also known as the first Rab protein
that was shown to be associated with human diseases (Seabra
et al., 2002). Mutations in RAB27A cause human type 2 Griscelli
syndrome (GS), which is characterized by pigment dilution in hair
(i.e., defect in melanosome transport in melanocytes) as well as
immunodeficiency (i.e., defect in granule exocytosis in cytotoxic
T lymphocytes; Me´nasche´ et al., 2000).
In melanocytes, Rab27A forms a transport complex with
Slac2-a/melanophilin (a Rab27-specific effector) (Kuroda et al.,
2002; Fukuda, 2003) and myosin Va (an actin-based motor).
The resulting tripartite protein complex regulates melanosome
transfer from microtubules to actin filaments as well as subse-
quent actin-based melanosome transport (Fukuda et al., 2002;
Wu et al., 2002; Kuroda et al., 2003; Hume et al., 2006). After
actin-based melanosome transport, Rab27A interacts with
Slp2-a, another Rab27-specific effector, and promotes the an-
choring of melanosomes to the plasma membrane (Kuroda
and Fukuda, 2004). The former interaction seems to be moreAll rights reserved
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Structure of the Rab27B/Slac2-a complexcrucial for melanosome transport, because mutations that abro-
gate the Rab27A/Slac2-a interaction—e.g., Rab27A W73G mis-
sense mutation found in type 2 GS (GS2) patients (Me´nasche´
et al., 2003a; Bahadoran et al., 2003; Fukuda, 2006a) and
Slac2-a R35W missense mutation found in type 3 GS (GS3) pa-
tients (Me´nasche´ et al., 2003b) disrupt melanosome transport
and thereby induce perinuclear aggregation of melanosomes.
The perinuclear aggregation phenotype of Rab27A-deficient
melanocytes can be rescued by the expression of Rab27B,
a closely related isoform of Rab27A (72% sequence identity;
Barral et al., 2002), consistent with the fact that all of the known
Rab27 effectors, including Slp2-a and Slac2-a, identified thus far
can bind both Rab27A andRab27B (Fukuda et al., 2002, Fukuda,
2003; Shirakawa et al., 2004). However, nothing is known about
the structural basis of the Rab27/Slac2-a interaction, although
this information is critical for the molecular diagnosis of human
GS as well as for understanding the mechanism by which
Table 1. X-ray Data Collection, Phasing, and Refinement
Statistics
SAD
Data collection
Wavelength (A˚) 0.97898
Resolution (A˚) 503.0 (3.13.0)
Unique reflections 23,600
Redundancy 10.5
Completeness (%) 99.9 (99.8)
I/s(I) 16.0 (2.5)
Rsym (%)
a 15.5 (78.1)
SAD analysis
Resolution (A˚) 15.04.0
No. of Se sites 10
No. of Zn sites 4
FOMSAD
b 0.30
FOMRESOLVE
c 0.62
Refinement
Resolution (A˚) 45.33.0
No. of reflections 23,411
No. of protein atoms 5,208
No. of GTP molecules 2
No. of magnesium ions 2
No. of zinc ions 4
No. of sulfate ions 2
No. of water molecules 9
Rwork (%) 24.7
Rfree (%)
d 29.6
Rmsd bond length (A˚) 0.008
Rmsd bond angles () 1.4
All numbers in parentheses represent last outer shell statistics.
aRsym = S jIavg-Iij / SIi, where Ii is the observed intensity and Iavg is the av-
erage intensity.
b Figure of merit after SOLVE phasing.
c Figure of merit after RESOLVE.
dRfree is calculated for 10% of randomly selected reflections excluded
from refinement.Structure 16, 1478Slac2-a specifically recognizes Rab27A/B, but not the other 58
Rabs, including Rab3.
In this study, we determined the 3.0 A˚ crystal structure of the
effector domain of mouse Slac2-a complexed with a GTPase-
deficient mutant (Q78L) of mouse Rab27B. As far as we know,
this is the first report of the crystal structure of a Rab-binding
domain that exclusively recognizes a single Rab subfamily
(i.e., Rab27). The structure revealed the residues involved in
the specific Rab27B/Slac2-a interaction. Furthermore, muta-
tional analyses of Rab27A and Rab3A identified the structural
determinants underlying the specific interaction of the Rab27
subfamily with Slac2-a.
RESULTS AND DISCUSSION
Structure Determination
To obtain structural information on the complex of mouse
Rab27B (218 residues) and Slac2-a (590 residues), we used
a C-terminally truncated form of the GTPase-deficient mutant
Rab27B(Q78L) (residues 1–201; hereafter designated Rab27B)
and the minimum region of Slac2-a that specifically binds to
the GTP-bound form of Rab27 (residues 1–146; hereafter desig-
nated Slac2-a; Kuroda et al., 2002; Fukuda et al., 2002, Fukuda,
2003). First, we expressed Slac2-a alone in the Escherichia coli
cell-free synthesis system, but the Slac2-a protein precipitated
and could not be recovered in the soluble fraction. In contrast,
when Slac2-a was coexpressed with Rab27B in the same sys-
tem, both proteins were expressed in soluble forms. The result-
ing Rab27B/Slac2-a complex was stable and monomeric with
1:1 stoichiometry, as determined by gel filtration (see Figure S1
available online).
The crystals of the Rab27B/Slac2-a complex formed in
the primitive tetragonal space group P41212, with unit cell con-
stants of a = b = 82.2 A˚, c = 325.5 A˚, and contained two
Rab27B/Slac2-a complexes per asymmetric unit. The structure
of the complex was determined by the single-wavelength anom-
alous dispersion (SAD) method, using the crystal of the seleno-
methionine-substituted proteins, and was refined to 3.0 A˚ reso-
lution (Figure S2). The crystallographic data are summarized in
Table 1. The final model includes two pairs of the Rab27B/
Slac2-a complex (A/C and B/D; A and B designate Rab27B,
and C and D designate Slac2-a), containing residues 5–188 of
Rab27B and residues 4–144 of Slac2-a, two GTP molecules,
twomagnesium ions, four zinc ions, two sulfate ions, and 9 water
molecules. Several residues in the interswitch regions of the
two Rab27B molecules (residues 59–61 of chain A and residues
56–65 of chain B) were not visible in electron density maps, and
thus were omitted from the final model. Because the structures
of the two copies of the Rab27B/Slac2-a complex in the asym-
metric unit are essentially the same, we describe only the struc-
ture of the A/C complex.
Overall Structure of the Rab27BSlac2-a Complex
A ribbon representation of the Rab27B/Slac2-a complex is
shown in Figure 1A. The structure contains the Rab27Bmolecule
in the GTP-bound form and the Slac2-a effector domain. In the
complex, Rab27B adopts a globular fold, and Slac2-a forms
an elongated helical fold with a subdomain that contains two–1490, October 8, 2008 ª2008 Elsevier Ltd All rights reserved 1479
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Structure of the Rab27B/Slac2-a complexzinc ions. The main interface between Slac2-a and Rab27B is
formed by the helical region of Slac2-a, and the switch, inter-
switch, and the Rab complementarity-determining regions
(RabCDRs) (Ostermeier and Brunger, 1999) of Rab27B
(Figure 1A). Becausemost of the residues involved in the interac-
tions with Slac2-a are conserved between Rab27A and Rab27B
(Figure 2A), we predicted that the interactive structures of
Rab27A and its complex with Slac2-a would be similar to those
observed in the Rab27B/Slac2-a complex.
The overall structure of the Rab27B/Slac2-a complex resem-
bles that of the Rab3A/rabphilin complex (Ostermeier and
Brunger, 1999; Figure 1B). This is consistent with the fact that
the Slac2-a and rabphilin effector domains exhibit significant se-
quence similarity (19% sequence identity), especially from the
Figure 1. Overall Structure of the Rab27B/
Slac2-a Complex and Comparison with the
Rab3A/Rabphilin Complex
(A) Ribbon representation of the Rab27B/Slac2-a
complex. The two views are related by a 180
rotation about the vertical axis. Rab27B is shown
in orange, except for switch 1, switch 2, and
RabCDRs, which are colored yellow, green, and
red, respectively. Slac2-a is shown in cyan. GTP,
Mg2+, and Zn2+ are represented as spheres.
(B) Ribbon representation of the Rab3A/rabphilin
complex. The molecular orientations are the
same as in (A). Rabphilin is shown in blue, and
the coloring scheme for Rab3A is the same as
that for Rab27B in (A).
synaptotagmin-like protein (Slp)-homol-
ogy domain 1 (SHD1) to the N-terminal
half of the Slp-homology domain 2
(SHD2) (Figure 2B; Fukuda et al., 2001;
Kuroda et al., 2002). However, we ob-
served significant differences in the struc-
tures of Slac2-a and rabphilin, aswell as in
the modes of interaction with Rab mole-
cules, supporting previous reports that
Slac2-a exclusively binds Rab27A/B,
whereas rabphilin is capable of binding
both the Rab3 and Rab27 isoforms (Kur-
oda et al., 2002; Fukuda, 2003, Fukuda
et al., 2004; discussed hereafter).
Among the other crystallographically
analyzed Rab/effector complexes, the
structures of two distinct effector do-
mains of rabenosyn-5 are helical hairpins,
each engaging Rab4 or Rab22 by the
specific recognition of their switch and in-
terswitch regions (Eathiraj et al., 2005).
The other Rab/effector complexes, such
as Rab5/rabaptin5 (Zhu et al., 2004),
Rab7/RILP (Wu et al., 2005), Rab11/FIP3
(Shiba et al., 2006; Eathiraj et al., 2006),
and Rab11/FIP2 (Jagoe et al., 2006),
share a dyad-symmetric complex, where
a parallel coiled-coil homodimeric effec-
tor interacts with two Rab molecules, using their switch and
interswitch regions. In contrast to the Rab27B/Slac2-a and
Rab3A/rabphilin complexes, none of these Rab/effector
complexes use the RabCDRs for the effector binding.
Structure of Rab27B
The structure of Rab27B in the complex contains a central six-
stranded b sheet flanked by five a helices (a1–5), similar to other
Ras-like small GTPases, with GTP and Mg2+ bound in the con-
served nucleotide-binding site (Figure 1A). The structure of
Rab27B in the complex is similar to that of Rab3A complexed
with rabphilin (rmsd 1.0 A˚ over 173 Ca atoms), which is consis-
tent with the evidence that Rab27 and Rab3 are phylogenetically
similar (Pereira-Leal and Seabra, 2001; Kuroda et al., 2002;
1480 Structure 16, 1478–1490, October 8, 2008 ª2008 Elsevier Ltd All rights reserved
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Structure of the Rab27B/Slac2-a complexFigure 2. Sequence Alignment of the Rab Proteins, and the Effector Domains of the Slp Family Proteins
(A) Sequence alignment of mouse Rab27A, Rab27B, and Rab3A. The secondary structures of Rab27B complexed with Slac2-a are shown above the sequences.
Switch 1, switch 2, and RabCDRs are indicated by yellow, green, and red bars, respectively. Asterisks indicate the contact residues of Rab27B in the Rab27B/
Slac2-a complex (orange) and those of Rab3A in the Rab3A/rabphilin complex (green). Positions of Rab27A and Rab3A residues that were mutated or inserted in
Figure 7 are indicated with arrowheads.
(B) Sequence alignment of Rab27-binding domains. The Slac2-a secondary structure is indicated above the sequences. The SHD1 and SHD2 regions are
indicated below the sequences. Asterisks indicate the contact residues of Slac2-a in the Rab27B/Slac2-a complex (orange) and those of rabphilin in the
Rab3A/rabphilin complex (green). Primary sequences used in the alignment: mouse Slac2-a (accession number BAB41087), mouse Slac2-c (BAC15554), mouse
Slac2-b (BAC57424), mouse Slp1 (Q99N80), mouse Slp2-a (BAB41082), mouse Slp3-a (BAB41086), mouse Slp4 (NP_038785), mouse Slp5 (BAC57421), mouse
Noc2 (Q768S4), and rat rabphilin-3A (P47709). This figure was generated by ESPript (Gouet et al., 1999).
Structure 16, 1478–1490, October 8, 2008 ª2008 Elsevier Ltd All rights reserved 1481
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Structure of the Rab27B/Slac2-a complexFukuda et al., 2004). However, slight but significant structural dif-
ferences exist in the b2–b3 loop (residues 55–64) and the a3–b5
loop (residues 122–126; Figure 3A), where there are gaps
between the Rab27B and Rab3A sequences (Figure 2A). In
the case of Rab27B, both of these regions are involved in
Slac2-a binding (Figure 1A), whereas in the case of Rab3A, the
a3–b5 loop is involved, but the b2–b3 loop is not involved, in rab-
philin binding (Figure 1B).
The structure of the GTP-bound Rab27B in this study
(Figure 3B, left panel) and those of other canonical small
GTPases adopt a compact monomer conformation. In contrast,
an extended conformation in a segment-swapped dimer was
observed in all four of the crystal structures of GDP-bound
Rab27B (PDB ID codes 2F7S, Wang et al., Structural Genomics
Consortium; 2IEZ, 2IEY, and 2IFO, Chavas et al., 2007;
Figure 3B, right panel). A comparison of the structure of
Rab27B/GTP in our complex with those of Rab27B/GDP re-
Figure 3. Structural Comparison of Rab27B
with Rab3A in Their Complexes, and with
Rab27B in the Absence of Bound Effector
(A) Stereo view showing a superimposition of the
Ca atoms of Rab27B/GTP and Rab3A/GTP in the
complexes with Slac2-a and rabphilin, respec-
tively. Switch1, switch 2, and RabCDRs in
Rab27B are colored as in Figure 1A, and Rab3A
is colored gray. Bound GTP molecules are repre-
sented as lines.
(B) Comparison of Rab27B/GTP complexed with
Slac2-a (left) and Rab27B/GDP (right). Switch 1,
switch 2, and RabCDR of Rab27B are colored as
in Figure 1A, Slac2-a is colored cyan, and the seg-
ment-swapping molecule of Rab27B/GDP in the
crystal is colored gray. Mg2+, GTP, GDP, and se-
lected residues of Rab27B are represented as
spheres.
(C) Stereo view showing a superimposition of the
Ca atoms of Rab27B/GTP in the complex and
Rab27B/GDP. For clarity, the switch and inter-
switch regions are omitted from this figure. The
coloring scheme for Rab27B/GTP in the complex
is the same as in (A), and Rab27B/GDP is colored
blue. Bound GTP, GDP, and selected residues are
represented as lines.
vealed significant differences in the con-
formations of switch 1, switch 2, and the
interswitch region, due to the segment
swapping in Rab27B/GDP. Switch 1 and
switch 2 of Rab27B/GTP in our complex
hydrogen bond with the g-phosphate of
the bound GTP (Figure 3B, left). As a re-
sult, the switch and interswitch regions
of Rab27B form part of the interface
with Slac2-a. However, switch 1 and
switch 2 of Rab27B/GDP exist com-
pletely apart from the bound GDP
(Figure 3B, right), and a docking analysis
showed that the resulting conformations
of the switch and interswitch regions are
incompatible with Slac2-a binding (data not shown). Therefore,
we suggest that Rab27B may undergo a conformational change
from the extended to the compact form upon GTP binding, as
a result of g-phosphate contacts with the switch regions. It is
likely that these conformational changes are required for the
subsequent binding of the effectors.
Another unique feature of the GDP-bound form of Rab27B is
the existence of an intramolecular disulfide bond, which was
observed in three (PDB ID codes 2F7S, 2IEZ, and 2IFO) of the
four different crystal forms. In these structures of Rab27B/
GDP, the a3 helix shifts and is partially melted, and the following
a3–b5 loop is connected to the C terminus of the a5 helix by
a Cys123-Cys188 disulfide bond (Figure 3C). This disulfide
bond is absent, however, in the Rab27B/GTP in our complex.
As a result, the a3–b5 loop gains conformational flexibility,
thus permitting Tyr122 to contribute to the formation of a hydro-
phobic pocket that interacts with the 117-SLEWYY-122 motif of
1482 Structure 16, 1478–1490, October 8, 2008 ª2008 Elsevier Ltd All rights reserved
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Structure of the Rab27B/Slac2-a complexSlac2-a (described hereafter). This conformational change of
Rab27B resembles the situation observed for the Rab3A/rab-
philin complex, where Rab3A exerts an induced-fit conforma-
tional change in the a3–b5 loop upon rabphilin binding (Oster-
meier and Brunger, 1999), although the intramolecular
disulfide bond is absent in Rab3A. In the fourth crystal form of
Rab27B/GDP (PDB ID code 2IEY), the Cys123-Cys188 disulfide
bond is not observed, and the conformation of the a3–b5 loop is
similar to that observed in the Rab27B/GTP in our complex
(data not shown). This suggests that the disulfide-bond forma-
tion in Rab27B does not depend on its nucleotide-binding state.
We predict that in the absence of Slac2-a, Rab27B/GTP as-
sumes a conformation similar to that observed in the Rab27B/
Slac2-a complex. It is likely that, without the binding of
Figure 4. Structural Comparison of Slac2-a
with Rabphilin
(A) Superimposition of the zinc-binding subdo-
mains of Slac2-a (cyan) and rabphilin (gray). The
eight cysteine residues, coordinating the two
zinc ions, are shown as sticks.
(B) Superimposition of the Rab27B/Slac2-a (col-
ored as in Figure 1A) and Rab3A/rabphilin (gray)
complexes.
(C) Superimposition of the Ca atoms of Slac2-a
(cyan) and rabphilin (gray). The three side-chain ar-
omatic rings from the Slac2-a 117-SLEWYY-122
motif and those from the rabphilin 150-SGAWFF-
155 motif are represented as cyan and gray lines,
respectively.
Slac2-a, the a3–b5 loop is more flexible,
and thus can form the disulfide bond be-
tween Cys123 and Cys188 more easily
during the crystallization.
Structure of Slac2-a
The structure of the Slac2-a effector do-
main comprises three subdomains:
SHD1, SHD2, and a zinc-binding subdo-
main that is flanked by the two SHDs
(Figures 1A and 2B; Fukuda, 2002).
SHD1 is folded into a 66 A˚-long helix
(a1), and SHD2 is composed of three he-
lices (a3–a5). SHD1 and SHD2 interact
with each other by making a coiled coil
between a1 and a3–a5, where a3 and
a5 interact with a1 in an antiparallel man-
ner (Figure 1A). The zinc-binding subdo-
main contains four short b strands (b1–
b4) and five loops (L1–L5), including three
short helices (a2, h1, and h2). The two
zinc ions (Zn1 and Zn2) are each coordi-
nated by four conserved cysteine resi-
dues: Cys64, Cys67, Cys89, and Cys92
for Zn1 binding, and Cys81, Cys84,
Cys104, and Cys107 for Zn2 binding (Fig-
ures 2B and 4A). A similar subdomain
structure exists in Slac2-c/MyRIP, Slp3-
a, Slp4, Slp5, Noc2, and rabphilin, though
there are several Rab27 effectors (Slp1, Slp2-a, and Slac2-b)
that lack a zinc-binding motif (Figure 2B).
A comparison of the structure of Slac2-a with that of rabphilin
revealed that they share common structural features, with re-
spect to the N-terminal long helix and the zinc-binding subdo-
main (Figure 1). As shown in Figure 4A, the structures of the
zinc-binding subdomains of Slac2-a and rabphilin adopt similar
folds (rmsd 2.0 A˚ over 52 Ca atoms). The structural differences
within the subdomain are restricted to the L1 and L5 loops (res-
idues 54–63 and 95–102), which differ in length between Slac2-a
and rabphilin (Figure 2B). In the L1 loop, there is a six-residue-in-
sertion that permits the formation of an additional short helix (a2)
in Slac2-a. The conformation of the Slac2-a L5 loop seems to be
affected by the interaction with Rab27B (see following text).
Structure 16, 1478–1490, October 8, 2008 ª2008 Elsevier Ltd All rights reserved 1483
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Structure of the Rab27B/Slac2-a complexA superposition of the overall structures of Slac2-a and rabphi-
lin in their complexes revealed significant structural differences.
The a1 helix of Slac2-a is straight, whereas the corresponding
helix of rabphilin is bent and shifts by about 12 (Figure 4B). As
a result, the relative orientation between the coiled coil and the
zinc-binding subdomain significantly differs. The relative orienta-
tion between a1 and the zinc-binding subdomain depends on
the conformation of the L1 loop (Figure 4A). Because the six-res-
idue insertions in the L1 loops are also found in Slac2-c, Slp3-a,
and Slp4 (Figure 2B), they may adopt structures similar to that of
Slac2-a, rather than rabphilin. However, the L1 loop of Noc2 has
the same length as that of rabphilin, and thus Noc2 probably as-
sumes a structure similar to that of rabphilin.
Other structural differences between Slac2-a and rabphilin
were observed in SHD2. In Slac2-a, the two side-chain aromatic
rings of Trp120 and Tyr121 in the 117-SLEWYY-122 motif adopt
a perpendicular, edge-to-edge conformation with Tyr122, and
participate in the interaction with Rab27B, as described hereaf-
ter. Similar conformations are observed for the corresponding
150-SGAWFF-155 motif of rabphilin, but the precise locations
of the side chains are slightly different (Figure 4C). This is consis-
tent with the structural difference between Rab27B andRab3A in
the a3–a5 loop (Figure 3A), which interacts with these aromatic
residues. In addition, the region following the 117-SLEWYY-
122 motif of Slac2-a is folded into two helices (a4 and a5),
whereas the corresponding region of rabphilin is extended (Os-
termeier and Brunger, 1999; Figure 4C). These structural differ-
ences are probably a reflection of the sequence variability (Fig-
ure 2B), because the amino acid sequences of rabphilin in the
region of the a4 and a5 helices are proline rich and therefore un-
able to form an a helix. Among the other Rab27 effectors, the
proline-rich sequence is only conserved in Noc2, and thus the
C terminus of Noc2 SHD2 may assume an extended conforma-
tion, as observed in rabphilin.
Rab27BSlac2-a Interface
Rab27B interacts with Slac2-a with a buried surface area of 2534
A˚2, which corresponds to 30.2% of the total surface area and in-
volvesmanyhydrophobic interactionsandseveral electrostatic in-
teractions (Figure5A). A calculationof the shapecorrelation statis-
tic (Sc) (LawrenceandColman, 1993) yieldeda valueof 0.66 for the
Rab27B/Slac2-a interface, showing thatRab27Bbinds to Slac2-a
with good shape complementarity. There are three contact areas
in the interface between Rab27B and Slac2-a. The first and sec-
ond contact areas involve the coiled-coil regions of Slac2-a and
constitute themain interface (Figure 5A). These areas correspond
to the two contact areas (A andB) presented in theRab3A/rabphi-
lin complex (Ostermeier and Brunger, 1999; Figure 5B). The third
contact area involves the zinc-binding subdomain of Slac2-a,
and is unique to the Rab27B/Slac2-a complex (Figure 5A).
The first contact area of the Rab27B/Slac2-a interface con-
sists of residues 6–9 from RabCDR, part of the switch and inter-
switch regions of Rab27B, and the coiled-coil regions of Slac2-a
(Figure 6A). Phe81, Leu84, and Phe88 from switch 2 of Rab27B
participate in hydrophobic interactions with the residues from a1
and a5 of Slac2-a. In addition, there are electrostatic interactions
that are conserved in the Rab3A/rabphilin complex (Figures 5
and 6A and 6B). Among the residues involved in these interac-
tions, Glu14, Val18, and Val21 of Slac2-a are required for1484 Structure 16, 1478–1490, October 8, 2008 ª2008 Elsevier LtdRab27A binding both in vitro (Fukuda, 2002) and in vivo (Kuroda
et al., 2003). Furthermore, Trp73 of Rab27B is located in themid-
dle of this contact area, and it plays a central role in the hydro-
phobic interactions (Figure 6A). This is perfectly consistent with
the previous reports that the Rab27A(W73G) mutation, which is
found in GS2 patients, abolished Slac2-a binding (Me´nasche´
et al., 2003a; Bahadoran et al., 2003; Fukuda, 2006a).
An analysis of the interactions at the first contact area, in the
context of the Slac2-a mutations found in human GS3 patients
(R35W) (Me´nasche´ et al., 2003b) and leaden mice (Matesic
et al., 2001), provides a molecular basis for the effects of these
mutations. In our Rab27B/Slac2-a structure, Arg35 engages in
a conserved electrostatic interaction with the Asp7 carbonyl
group of Rab27B (Figure 6A). Nearby, Glu32 of Slac2-a forms
a hydrogen bond with Tyr6 of Rab27B, which is specific in the
Rab27B/Slac2-a complex. In the Rab3A/rabphilin complex, the
Rab3A residue that corresponds to Tyr6 of Rab27B is Phe19,
which cannot be involved in the hydrogen-bonding interaction
with rabphilin (Figure 6B). A seven-amino-acid deletion (residues
31–37) of Slac2-a,whichwas found in leadenmice (Matesic et al.,
2001), abrogates Rab27A-binding activity (Fukuda, 2002). Based
on the structure, we suggest that this is due to the absence of the
Glu32-Tyr6 and Arg35-Asp7 hydrogen bonds.
In the first contact area, additional hydrogen bonds that are
specific to Rab27B/Slac2-a were observed. First, Asp91 of
Rab27B, which confers a negative charge in the center of the in-
terface with Slac2-a (Figure 5A), hydrogen bonds with Arg29 and
Gly133 of Slac2-a (Figure 6A). However, the corresponding posi-
tion of Rab3A is occupied by glycine (Gly94) and is not involved
in the electrostatic interaction with rabphilin (Figure 6B). Consis-
tent with this, the Rab27B(D91G) mutant hardly binds Slac2-a,
but retains the ability to bind rabphilin (Fukuda, 2002). Second,
the Ile44 carbonyl group of Rab27B hydrogen bonds with
His17 of Slac2-a (Figure 6A). His17 of Slac2-a is conserved in
Slac2-c (Figure 2B), and thus may play an additional role in the
specific interaction with Rab27 in Slac2-a and Slac2-c. Third,
Arg90 of Rab27B forms a hydrogen bond with the Arg131 car-
bonyl group from the a4–a5 loop of Slac2-a (Figure 6A). The cor-
responding arginine residue (Arg93) of Rab3A is not involved in
the interaction with rabphilin because of the structural differ-
ences in SHD2 between Slac2-a and rabphilin (Figure 6B).
The second contact area consists of a pocket on the surface of
the RabCDRs of Rab27B, which accommodates the side chains
of the residues from the 117-SLEWYY-122 motif of Slac2-a (Fig-
ure 6C). At this interface, there are extensive hydrophobic inter-
actions and three hydrogen bonds that are specific to the
Rab27B/Slac2-a complex. Tyr121 of Slac2-a hydrogen bonds
with the Arg90 carbonyl group of Rab27B, whereas Arg128 of
Slac2-a,which is highly conservedamong theSlp-family proteins
(Figure 2B),makes two hydrogen bondswith the carbonyl groups
ofGln118 andAla121 of Rab27B. These observations are consis-
tent with previous studies showing that the SHD2 region of
Slac2-a is required for high-affinity recognition of Rab27A, as well
as formelanosomal localization (Fukuda, 2006b;Humeetal., 2006).
A comparisonof the secondcontact area of theRab27B/Slac2-a
interface to that of Rab3A/rabphilin (Figures 6C and 6D) revealed
significant structural differences in thea3–b5 loopof theRabmol-
ecules as well as in the interacting regions of the effectors. In
Rab27B, the side chain of Tyr122 in the a3–b5 loop protrudesAll rights reserved
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and Tyr121 of Slac2-a (Figure 6C). In contrast, the corresponding
residue of Rab3A (Trp125) is rotated away from the pocket
(Figure 6D). The deletion of theRab27ATyr122-Cys123sequence
and its mutation to the corresponding residue (Trp) of Rab3A (the
YC122/123W mutation of Rab27A) had little effect on Slac2-a
binding (Fukuda, 2002), suggesting that Rab27 Tyr122 is not es-
sential for the specific interaction between Rab27 and Slac2-a.
The third contact area consists of the protruding b2–b3 loop of
Rab27B and the L5 loop of the Slac2-a zinc-binding subdomain
Figure 5. Comparison of the Surface Elec-
trostatic Charges at the Rab27B/Slac2-a
and Rab3A/Rabphilin Interfaces
(A) Rab27B (left panel) and Slac2-a (right panel) in
the Rab27B/Slac2-a complex.
(B) Rab3A (left panel) and rabphilin (right panel) in
the Rab3A/rabphilin complex. Blue and red sur-
faces represent positive and negative potentials,
respectively. The three contact areas in the
Rab27B/Slac2-a complex and contacts A and B
in the Rab3A/rabphilin complex are indicated
with dashed lines. The locations of selected resi-
dues are indicated. This figure was generated us-
ing CCP4 MG (Potterton et al., 2004).
(Figures 1A and 6E). The interactions in
this area are exclusively hydrophobic,
and no polar interaction is observed
(Figure 5A). Because most of the interact-
ing residues of Rab27B (Thr55, Gln56,
Gly63, Lys64, and Phe66) are not con-
served in Rab27A (Figure 2A), the interac-
tions in this area may not be essential for
the Rab27/Slac2-a interaction.
The corresponding interactions of the
third contact area are absent from the
Rab3A/rabphilin complex, because
Rab3A has a shorter b2–b3 loop than
Rab27B (Figures 2A and 6F). In addition,
due to the different subdomain orienta-
tions between rabphilin and Slac2-a (Fig-
ure 4C), the L5 loop could not reach the
b2–b3 loop of Rab3A. The L5 loop se-
quences of other Rab27 effectors that
contain zinc-binding motifs are divergent,
and there are several Rab27 effectors
that lack a zinc-binding motif (Figure 2B),
suggesting that the third contact area ob-
served in the Rab27B/Slac2-a complex
structure is dispensable for the recogni-
tion of other Rab27 effectors.
Mutational Experiments on Rab27A
and Rab3A
As described previously, most of the res-
idues involved in the interaction with
Slac2-a are highly conserved between
Rab27A/B and Rab3A (Figure 2A), except
for Tyr6 from RabCDR and Asp91 from switch 2, which are in-
volved in the formation of specific hydrogen bonds between
Rab27B and Slac2-a (Figure 6A). To evaluate these interactions,
we created a series of Rab27A mutants in which Tyr6 and/or
Asp91 were mutated to the corresponding residues of Rab3A.
As shown in Figure 7A (lane 2), the single mutation of Y6F in
Rab27A almost completely abolished Slac2-a binding. The sin-
gle mutation of D91G in Rab27A also dramatically reduced
Slac2-a binding (Figure 7A, lane 3). In addition to these muta-
tions, Leu84 and Phe88 from switch 2 of Rab27A, which are
Structure 16, 1478–1490, October 8, 2008 ª2008 Elsevier Ltd All rights reserved 1485
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ure 6A), were further mutated. As expected, the resulting Y6F/
L84I/F88Y/D91G Rab27A mutant was unable to bind Slac2-a
at all (Figure 7A, lane 4).
In comparison with Rab3A, two additional insertions were
found in Rab27A (Tyr122 in the a3–b5 loop and Gly57-Pro58-
Asp59-Gly60-Ala61-Val62-Gly63-Arg64-Gly65 in the b2–b3
loop; Figure 2A). However, these insertions are not essential
for the specific recognition by Slac2-a, because we previously
showed that the Rab27A(YC122/123W) mutant still exhibited
Slac2-a binding activity (Fukuda, 2002), and the deletion of
Figure 6. Comparison of the Rab27B/
Slac2-a and Rab3A/Rabphilin Interfaces
(A)Contact area 1 in theRab27B/Slac2-a complex,
showing the interactions between the switch, in-
terswitch, and N-terminal regions of Rab27B and
two helices (a1 and a5) of Slac2-a. Hydrogen
bonds are indicated by yellow dashed lines.
(B) Contact area A in the Rab3A/rabphilin
complex.
(C) Contact area 2 in the Rab27B/Slac2-a com-
plex, showing the interactions between the
RabCDRs of Rab27B and the 117-SLEWYY-122
motif of Slac2-a.
(D) Contact area B in the Rab3A/rabphilin
complex.
(E) Contact area 3 in theRab27B/Slac2-a complex,
showing the interactions between the b2–b3 loop
of Rab27B and the zinc-binding subdomain of
Slac2-a, with superposition of their molecular
surfaces.
(F) The corresponding area of the Rab3A/rabphilin
complex.
the 57-GPDGAVGRG-65 sequence
(DGPDGAVGRG) had no effect on the
Slac2-a binding activity (Figure 7C, lane
2). In addition, Rab3A mutants with an
additional sequence corresponding to
the Tyr122 and/or 57-GPDGAVGRG-65
of Rab27A were unable to bind Slac2-a
(Figure 7D, lanes 2–4), indicating that
these insertions are not sufficient to con-
fer the Slac2-a binding ability to Rab3A.
Finally, we mutated the Rab3A resi-
dues that correspond to the aforemen-
tioned Rab27 residues (Tyr6, Leu84,
Phe88, and Asp91) and evaluated the ef-
fect of the mutations on the Slac2-a bind-
ing. Like wild-type Rab3A, neither the
F19Y nor G94D Rab3A mutant was able
to bind Slac2-a (Figure 7B, lanes 1–3), in-
dicating that the singlemutations of these
residues are not sufficient to confer the
Slac2-a binding ability on Rab3A. Simi-
larly, the F19Y/G94D and I87L/Y91F/
G94D Rab3A mutants did not bind to
Slac2-a at all (Figure 7B, lanes 4–5). How-
ever, the F19Y/I87L/Y91F/G94D Rab3A
mutant substantially bound Slac2-a (Figure 7B, lane 6), although
the Slac2-a binding activity of the Rab3A mutant was weaker
than that of wild-type Rab27A (Figure 7A, lane 1). These findings
strongly suggested that Tyr6 from RabCDR and three residues
(Leu84, Phe88, and Asp91) from switch 2 of Rab27 are the min-
imum determinants of Slac2-a binding.
Sequence Comparison with Other Rab27 Effectors
The present crystal structure and the structure-based mutagen-
esis revealed that Slac2-a recognizes the Rab27 isoforms with
Tyr6, Leu84, Phe88, and Asp91, which interact with the coiled
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Structure
Structure of the Rab27B/Slac2-a complexFigure 7. Specific Hydrogen Bonds Are Re-
quired for the Rab27A/Slac2-a Interaction
(A) Interaction between the T7-Slac2-a-SHD and
FLAG-Rab27Amutants, as revealed by a coimmu-
noprecipitation assay in COS-7 cells. Coimmuno-
precipitated (IP) FLAG-Rab27A mutants and
immunoprecipitated T7-Slac2-a-SHD proteins
are shown in the middle and lower panels, respec-
tively. The upper panel indicates the total ex-
pressed FLAG-Rab (1/80 volume of the reaction
mixture; input) used for immunoprecipitation.
Note that a single amino acid substitution, which
disrupts specific hydrogen bond formation be-
tween Rab27A and Slac2-a, resulted in the almost
complete loss (Y6F; lane 2) or the dramatic reduc-
tion (D91G; lane 3) of Slac2-a binding activity.
(B) Specific interaction between T7-Slac2-a-SHD
and FLAG-Rab3Amutants, as revealed by a coim-
munoprecipitation assay in COS-7 cells (see [A]).
Note that the F19Y/I87L/Y91F/G94D mutations in
Rab3A can confer the Slac2-a binding ability
(lane 4), although the Slac2-a binding activity of
Rab3A(F19Y/I87L/Y91F/G94D) is weaker than
that of Rab27A.
(C) Specific interaction between T7-Slac2-a-SHD
and the FLAG-Rab27A mutant, as revealed by
a coimmunoprecipitation assay in COS-7 cells
(see [A]). Note that the deletion of residues 57–65
(DGPDGAVGRG) in Rab27A had no effect on the
Slac2-a binding ability (lane 2).
(D) Specific interaction between T7-Slac2-a-SHD
and FLAG-Rab3Amutants, as revealed by a coim-
munoprecipitation assay in COS-7 cells (see [A]).
Note that neither the Y insertion nor the
GPDGAVGRG insertion in Rab3A conferred the
Slac2-a binding ability (lanes 2–4). The positions
of the molecular mass markers (in kilodaltons)
are shown on the left.coil, mostly in the a1 region, of Slac2-a (Figure 6A and Fig-
ure S2). The sequence divergence in the coiled-coil regions of
the Rab27 effectors is therefore likely to affect their Rab27-bind-
ing affinities. The ten Rab27 effectors are classified into two
groups in terms of their Rab27A-binding affinity: a high-affinity
group (Slp1, Slp2-a, Slp4-a, Slp5, Slac2-b, Noc2, and rabphilin)
and a low-affinity group (Slac2-a, Slac2-c, and Slp3-a, under-
lined in Figure 2B) (Fukuda, 2006a). A comparison of the
Rab27-interacting residues in a1 between these effectors re-
vealed that most of the Rab27-interacting residues of Slac2-a
are conserved in rabphilin and the other Rab27 effectors
(Figure 2B). However, we observed several amino acid replace-
ments that may account for the differences in the Rab27-bind-
ing affinity between the Rab27 effectors. Val18 of Slac2-a is
conserved in Slac2-c, another low-affinity group member, but
is replaced with Ile in all of the high-affinity group members, in-
cluding rabphilin. We suggest that the Ile side chain in this po-
sition may more snugly interact with Rab27 in the high-affinity
group members. Similarly, Val22 of Slac2-a and Slac2-c is re-
placed with Ile or Leu in the high-affinity group members. The
other low-affinity group member, Slp3-a, shares these residues
with the high-affinity group members, but possesses Val28,
rather than the Leu or Met found in the other effectors. In addi-
tion, Slp3-a possesses Phe10, rather than the Leu found in all of
the other effectors. It is possible that the combination of theseStructure 16, 1478amino acid replacements in the Rab27 effectors may alter the
affinity for Rab27.
Conclusions
Slac2-a is the first mammalian Rab effector protein that has been
thoroughly investigated in terms of Rab-binding specificity (i.e.,
specific recognition of Rab27 isoforms; Kuroda et al., 2002; Fu-
kuda et al., 2002; Fukuda, 2002). Slac2-a mediates actin-based
melanosome transport in melanocytes via interactions with
Rab27A on the melanosome and myosin Va (Fukuda et al.,
2002; Wu et al., 2002; Kuroda et al., 2003; Hume et al., 2006).
Mutations that abrogate the Rab27A/Slac2-a interaction cause
human GS (Me´nasche´ et al., 2003a, 2003b; Bahadoran et al.,
2003; Fukuda, 2006a) and leadenmice (Matesic et al., 2001; Fu-
kuda, 2002). Several amino acid residues in Slac2-a have previ-
ously been proposed to be involved in the specific recognition of
Rab27, based on a sequence comparison between various
Rab-binding domains combined with site-directed mutagenesis
(Fukuda, 2002).
In the present study, we solved the crystal structure of the
Slac2-a effector domain complexed with Rab27B(Q78L). It re-
vealed three contact areas in the interface between Rab27B
and Slac2-a. The first contact area involves the coiled-coil re-
gions of Slac2-a and the switch, interswitch, and RabCDR re-
gions of Rab27B, which can explain the structural basis of the–1490, October 8, 2008 ª2008 Elsevier Ltd All rights reserved 1487
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comparison of the Rab27B/Slac2-a complex with the Rab3A/
rabphilin complex (Ostermeier and Brunger, 1999) and struc-
ture-based mutagenesis showed the specific Rab27 recognition
by Slac2-a involving this contact area. In contrast, the second
contact area, which involves the Rab27B RabCDR and the
Slac2-a 117-SLEWYY-122 motif, and the third contact area,
which consists of the extended b2–b3 loop of Rab27B and the
Slac2-a zinc-binding subdomain, are not fundamentally required
for the specificity of the interaction.We revealed the essential role
of the Rab27 Tyr6 residue from RabCDR for the Slac2-a binding,
in contrast to the previous findings that other Rab effectors pos-
sessing helical hairpins or parallel coiled coils use only the switch
and interswitch regions for the recognition of Rabs. Our struc-
ture-basedmutagenesis of Rab3A revealed that Rab3A is unable
to bind Slac2-a because it lacks the residues that correspond to
Tyr6, Leu84, Phe88, and Asp91 of Rab27. Inspection of the
sequence alignment of other Rab27 effectors suggests that the
differences in their Rab27A-binding affinities are mainly caused
by the amino acid replacements in the SHD1 region, which inter-
acts with Tyr6, Leu84, Phe88, and Asp91 of Rab27.
EXPERIMENTAL PROCEDURES
The cDNAs encoding mouse Rab27B(Q78L) (Fukuda et al., 2002) and the ef-
fector domain of mouse Slac2-a/melanophilin were each amplified by PCR.
The amplified Rab27B(Q78L) and Slac2-a cDNA fragments were indepen-
dently subcloned into the pCR2.1 vector (Invitrogen).
The Rab27B(Q78L) mutant (residues 1–201) and Slac2-a (residues 1–146)
were produced as fusion proteins with an N-terminal histidine-affinity tag
and a tobacco etch virus (TEV) protease cleavage site. The selenomethionine
(SeMet)-substituted proteins were synthesized by the E. coli cell-free system,
using the dialysis method (Kigawa et al., 2004; Wada et al., 2003). The internal
solution, including both plasmids, Rab27B and Slac2-a in pCR2.1, was dia-
lyzed in dialysis tubes (Spectra/Por 7 MWCO, 15000; Spectrum) against the
external solution at 30C for 4 hr with shaking. For the synthesis of the proteins,
50 mM of zinc chloride was added to both the internal and external solutions.
After the dialysis, the internal solution was centrifuged at 16,000 g at 4C for
20 min. The supernatant was loaded on a HiTrap Chelating (GE Healthcare
Bio-Sciences) column and eluted with 50 mM Tris-HCl buffer (pH 8.0) contain-
ing 200 mM NaCl, 2.5 mMMgCl2, 10% glycerol, 20 mM ZnCl2, 1 mM GTP, and
500 mM imidazole. The histidine-affinity tag was cleaved by TEV protease at
4C for 12 hr. To separate the histidine-affinity tag and the TEV protease, the
reaction solution was loaded on a HiTrap Chelating column, and the flow-
through fractions were collected. Next, the protein complex was further puri-
fied by ion exchange on a HiTrap Q (GE Healthcare Bio-Sciences) column
and by size-exclusion chromatography on a HiLoad 16/60 Superdex 75 (GE
Healthcare Bio-Sciences) column, pre-equilibrated with 20mMTris-HCl buffer
(pH 8.0) containing 150 mM NaCl, 2.5 mM MgCl2, 5% glycerol, 10 mM ZnCl2,
2.5 mM GTP, and 2 mM DTT.
The molecular mass of the purified Rab27B/Slac2-a complex was analyzed
by size-exclusion chromatography. The sample was applied to a Superdex 75
HR10/30 (GE Healthcare Bio-Sciences) column and eluted with 20 mM Tris-
HCl buffer (pH 8.0) containing 150 mM NaCl, 2 mM MgCl2, and 5 mM 2-mer-
captoethanol. The flow rate was 0.3 ml/ml and the UV absorbance at 280 nm
wasmonitored. Calibration of themolecular masswas carried out using bovine
albumin (66 kDa), egg albumin (45 kDa), carbonic anhydrase (29 kDa), trypsin
inhibitor (20.1 kDa), and a-lactalbumin (14.2 kDa) as standards.
Protein Crystallization and Data Collection
The crystallization screening of the Rab27B/Slac2-a complex was carried out
by the sitting-drop vapor-diffusion method (protein at 8 mg/ml) at 20C. Dif-
fraction-quality crystals of the complexwere grown against a reservoir solution
containing 1.65 M ammonium sulfate and Tris-HCl (pH 7.6) by the hanging-1488 Structure 16, 1478–1490, October 8, 2008 ª2008 Elsevier Ltddrop vapor-diffusion method. Single crystals were coated with Paratone-N
and 10% glycerol, mounted using a nylon loop (Hampton Research) and flash
cooled in the cold stream of the goniometer. The SAD data were collected at
100 K with a wavelength of 0.97898 A˚ at BL41XU, SPring-8 (Harima). The
wavelength was chosen to optimize the anomalous signals by measuring
the X-ray fluorescence spectrum. The diffraction data were processed with
the HKL2000 program (Otwinowski and Minor, 1997).
Structure Determination and Refinement
The program SOLVE (Terwilliger and Berendzen, 1999) was used to locate the
selenium and zinc sites and to calculate the initial phases, and RESOLVE was
used for the density modification (Terwilliger, 2000). Attempts to model the
structure by automatic tracing using RESOLVE BUILD (Terwilliger, 2003)
were unsuccessful because of the moderate resolution of the data. Thus, an
initial model was manually built using the structure of the Rab3A/rabphilin
complex (PDB ID code 1ZBD) as a guide. The model was corrected iteratively
using O (Jones et al., 1991), and structure refinement was carried out using
crystallography and NMR system (CNS) (Bru¨nger et al., 1998). Refinement sta-
tistics are presented in Table 1. The quality of the model was inspected by the
program PROCHECK (Laskowski et al., 1993). Structural similarities were cal-
culated with DALI (Holm and Sander, 1993). The solvent accessible surface
areas were calculated with the program AREAIMOL (CCP4, 1994). Graphic
figures were created with the program PyMOL (DeLano, 2002).
Plasmid Construction and Cotransfection Assay in COS-7 Cells
Mutant Rab3A plasmids carrying the F19Y mutation, the G94D mutation, the
I87L/Y91F/G94D mutations, the Y insertion between amino acid positions
124 and 125 (named +Y), and the GPDGAVGRG insertion between amino
acid positions 68 and 69 (named +GPDGAVGRG) were constructed by con-
ventional PCR techniques, using the following oligonucleotides with restriction
enzyme sites (underlined) and substituted or inserted nucleotides (italics):
50-GGATCCATGGCTTCCGCCACAGACTCTCGCTATGGGCAGAAGGAGTCCT
CAGACCAGAACTACGAC-30 (Rab3A-F19Y primer; sense); 50-GGTACCG
CACCATCACCACAGCCTATTACCGAGACGCCATG-30 (Rab3A-G94D primer;
sense); 50-GGTACCGCACCCTCACCACAGCCTTTTACCGAGACGCCATG-30
(Rab3A-I87L/Y91F/G94D; sense); 50-CAAGTACTGCTGGTGGGAAACAAGT-30
(+Y primer; sense) and 50-CAGTACTTGGGCATTGTCCCAGTACGAGTAAG
TTTTGATCTG-30 (+Yprimer; antisense); and 50-GGGCCCGATGGAGCTGTGG
GCCGAGGCAAGAGGATCAAGCTGCAGATCT-30 (+GPDGAVGRG; sense)
and 50-GGGCCCGTCGTTGCGGTAGATGGTTT-30 (+GPDGAVGRG; anti-
sense). The mutant Rab27A plasmid carrying the Y6F mutation and the
GPDGAVGRG deletion (i.e., deletion of residues 57–65) was also constructed
with the following oligonucleotides with restriction enzyme sites (underlined)
and a substituted nucleotide (italics): 50-GGATCCATGTCGGATGGAGATT
TCGAT-30 (Rab27A-Y6F primer; sense) and 50-CTGCAGGTGGATTCTCT
GATTGGCTCTGTACACCACTC-30 (Rab27A-D57–65 primer; antisense). The
mutant Rab3A and Rab27A fragments were subcloned into the pEF-FLAG-
tag vector (Fukuda, 2002) with the appropriate restriction enzyme sites and
were verified by DNA sequencing. Other Rab27Amutants [i.e., Rab27A(D91G),
Rab27A(L84I/F88Y/D91G), and Rab27A(YC122/123W)] were prepared as
described previously (Fukuda, 2002, 2003).
Transfection of pEF-T7-Slac2-a-SHD and pEF-FLAG-Rab3/27 into COS-7
cells was performed with LipofectAmine PLUS reagents (Invitrogen), accord-
ing to the manufacturer’s recommendations. Coimmunoprecipitation assays,
SDS-PAGE, and immunoblotting with horseradish peroxidase (HRP)-conju-
gated anti-FLAG tag and anti-T7 tag antibodies were performed as described
previously (Fukuda and Kanno, 2005).
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